By Deirdre Saulet and Julia Venanzi
In our recent look at the top threats to cancer program growth, survey respondents were most concerned about the cost of new drugs, physician alignment around services and goals, changes in health care coverage, and cuts to fee-for-service reimbursement. Some of those concerns, like cuts to fee-for-service reimbursement, are driven by changes in payer policy.
To further understand the impact of commercial and government payer policies, we asked respondents how they are responding to these changes.
Next, Check Out
2017 survey results: The top cancer program threats and opportunities